Lakeshore Biotechnology announced that it has received $31,400,000 in angel round of funding on January 10, 2022. The transaction included participation from Legend Capital Management LLC, Legend Holdings Corporation and angel investors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 HKD | -0.51% | +3.00% | -20.65% |
May. 03 | Star Plus Legend Completes HK$222 Million Share Placement | MT |
Apr. 29 | Star Plus Legend 2023 Profit Nearly Halves Despite Higher Revenues | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.65% | 1.7B | |
+72.13% | 93.94B | |
+0.47% | 22.33B | |
+7.38% | 18.91B | |
-4.95% | 14.92B | |
-3.86% | 12.99B | |
-2.96% | 10.51B | |
+13.03% | 10.33B | |
+13.59% | 10.19B | |
+17.75% | 9.33B |
- Stock Market
- Equities
- 3396 Stock
- News Legend Holdings Corporation
- Lakeshore Biotechnology announced that it has received $31.4 million in funding from Legend Capital Management LLC, Legend Holdings Corporation and other investors